GlassScriptPhysician profile
Jeffrey P Davis
NPI 1285675413
$3,151.36
in general payments reported to CMS, 2019-2025
40 companies · $462 in 2025
The $462 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $825 · 2020: $374 · 2021: $536 · 2022: $518 · 2023: $295 · 2024: $141 · 2025: $462.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $898.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $898.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $579.00 | 2019-2025 | Xifaxan, Trulance |
| Abbvie INC. | $350.45 | 2019-2022 | |
| Amgen INC. | $270.27 | 2019-2023 | Repatha |
| Novo Nordisk INC | $165.27 | 2019-2023 | |
| Astrazeneca Pharmaceuticals LP | $154.04 | 2020-2025 | Airsupra, Breztri |
| Amarin Pharma, INC. | $124.95 | 2019 | |
| Medtronic, INC. | $122.70 | 2022 | |
| Abbott Laboratories | $121.71 | 2022-2024 | Freestyle Libre 3 |
| Ibsa Pharma INC. | $114.82 | 2020-2024 | Tirosint, Licart, Licart |
| Antares Pharma, INC. | $106.27 | 2019-2025 | Xyosted |
| Urovant Sciences INC | $79.23 | 2021-2022 | |
| Clarus Therapeutics INC. | $74.70 | 2021 | |
| Astellas Pharma US INC | $64.88 | 2019-2020 | |
| Dexcom, INC. | $64.57 | 2024-2025 | Dexcom G6 Transmitter |
| Evofem Biosciences, INC. | $63.93 | 2021-2022 |
Show all 39 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.